Phosphorylation of tyrosine 992, 1068, and 1086 is required for conformational change of the human epidermal growth factor receptor c-terminal tail.
about
EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastomaA comprehensive pathway map of epidermal growth factor receptor signalingGlycosylation-induced conformational modification positively regulates receptor-receptor association: a study with an aberrant epidermal growth factor receptor (EGFRvIII/DeltaEGFR) expressed in cancer cells.Multiple-state reactions between the epidermal growth factor receptor and Grb2 as observed by using single-molecule analysis.Early events in M-CSF receptor signaling.Mass spectrometry mapping of epidermal growth factor receptor phosphorylation related to oncogenic mutations and tyrosine kinase inhibitor sensitivity.Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells.Oleanolic acid induces migration in Mv1Lu and MDA-MB-231 epithelial cells involving EGF receptor and MAP kinases activation.Molecular biology of gynecological cancer.Phosphorylated epidermal growth factor receptor and cyclooxygenase-2 expression in localized non-small cell lung cancerEntry of herpes simplex virus mediated by chimeric forms of nectin1 retargeted to endosomes or to lipid rafts occurs through acidic endosomes.Anticancer effects of ZD6474, a VEGF receptor tyrosine kinase inhibitor, in gefitinib ("Iressa")-sensitive and resistant xenograft models.Cetuximab response of lung cancer-derived EGF receptor mutants is associated with asymmetric dimerizationChronic sun exposure-related fusion oncogenes EGFR-PPARGC1A in cutaneous squamous cell carcinoma.Signaling pathways of isoproterenol-induced ERK1/2 phosphorylation in primary cultures of astrocytes are concentration-dependent.EGFR-independent activation of p38 MAPK and EGFR-dependent activation of ERK1/2 are required for ROS-induced renal cell death.
P2860
Q24338526-D2A1992E-3701-4220-A39A-62C41C8CD16AQ24672490-C2EAD637-BF62-4EC7-B5FC-FE64AC601A87Q27863678-0EB28D81-B790-4C6B-B55A-06F7F7853FD5Q30480710-E45E1E6D-2C1C-44C6-A5B2-C08CE3ED9B31Q33855769-D8CE9DAB-B20B-4A3F-ACDA-825212E13218Q34631999-E8E011EB-9B9D-4E75-A016-220996BC6888Q35804765-0306504B-81C0-4808-9F9D-2A4FFADA6120Q36288371-500B997F-886C-4F53-BC69-7E480BDB6D3EQ36502779-CE425A24-FA20-4742-BC28-C46675D5B326Q36717778-61A55BF2-DA89-43B7-81AF-D0D804B1735EQ40277858-C2127858-D8C6-4D21-8BE2-8DCF9B4A20F0Q40481337-6A5D7CE5-F2E6-43C1-8018-94C140D52695Q41894424-339C746E-5952-4E17-B3A8-13306C143E07Q42157310-FE51E5A2-2C2C-4B8E-808E-E8C91C233939Q42910843-3D0D7816-0AD6-4F85-86C3-F6CF707BE573Q47266364-DCB834B1-0B6D-4AE4-B30B-8A72C829A353
P2860
Phosphorylation of tyrosine 992, 1068, and 1086 is required for conformational change of the human epidermal growth factor receptor c-terminal tail.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Phosphorylation of tyrosine 99 ...... ctor receptor c-terminal tail.
@en
type
label
Phosphorylation of tyrosine 99 ...... ctor receptor c-terminal tail.
@en
prefLabel
Phosphorylation of tyrosine 99 ...... ctor receptor c-terminal tail.
@en
P2093
P2860
P356
P1476
Phosphorylation of tyrosine 99 ...... ctor receptor c-terminal tail.
@en
P2093
A Bishayee
L Beguinot
S Bishayee
P2860
P304
P356
10.1091/MBC.10.3.525
P577
1999-03-01T00:00:00Z